Clobetasol Propionate

Treats moderate to severe scalp psoriasis in subjects 18 years of age and older. Sold as Temovate, Temovate E, Olux, Clobex, Olux E and 3 more. Every FDA application for this active ingredient: 13 branded and 87 generic.

As of Nov 15, 2026, FDA lists 100 applications for Clobetasol Propionate (sold as Temovate, Temovate E, Olux and others), first approved Dec 27, 1985, with 2 new uses approved and 0 published complete response letters.

• First approved: Dec 27, 1985
• Applications: 100
• New uses approved: 2
• Complete response letters: 0
• Medicare spending, 2025: $131M